GE Healthcare falls after China begins anti-dumping probe into medical imaging equipment

Shares of medical equipment maker GE Healthcare GEHC.O fall 13.5% to $62.25

China launches an anti-dumping probe into imports of certain medical X-ray tubes used in CT scans from the U.S.

China also announces export curbs on some medium and heavy rare-earth metals, including gadolinium, which is used in MRI scans

China, which contributed ~12% of GEHC's revenue in 2024, is one of the key markets where majority of products sold are imaging equipment

"The risk is that any ruling from the (Chinese) ministry could impact tender processes and sales within a key market," BTIG analysts say

"It is clear that the Chinese government is taking steps to prop up a historically lagging medical device industry, and will likely take more proactive measures in the future to favor local Chinese MedTech vs foreign competition" - J.P.Morgan analysts

An anti-dumping investigation examines whether goods imported into a country are being sold at prices lower than their domestic market prices

Including session moves, GEHC down ~20% vs ~1% decline in S&P Healthcare Equipment .SPLRCMED YTD